Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 04/20/2026 at 22:15, 2 months 5 days ago

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Jaguar Health, Inc. announces voting results of Special Meeting of Stockholders with five approved proposals for novel prescription drugs derived from plants for GI and mental health indications

Forward-looking Statements Special Meeting Jaguar Health Stockholders Prescription Drugs
BRIEF

published on 04/13/2026 at 14:35, 2 months 12 days ago

Jaguar Health explore l'IA dans le développement du crofélémer pour l'insuffisance intestinale

Jaguar Health L'IA Dans Le Secteur De La Santé Développement Crofelemer Traitement MVID Insuffisance Intestinale
BRIEF

published on 04/13/2026 at 14:35, 2 months 12 days ago

Jaguar Health Explores AI in Crofelemer Development for Intestinal Failure

Jaguar Health AI In Healthcare Crofelemer Development MVID Treatment Intestinal Failure
PRESS RELEASE

published on 04/13/2026 at 14:30, 2 months 12 days ago

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Jaguar Health plans to utilize AI platforms to enhance the development and commercialization of crofelemer for intestinal failure treatment, targeting ultrarare pediatric disorder MVID

Crofelemer Jaguar Health MVID AI Platforms Intestinal Failure
BRIEF

published on 04/10/2026 at 02:20, 2 months 15 days ago

Jaguar Health programme une webdiffusion pour les investisseurs sur ses résultats financiers du quatrième trimestre 2025.

Jaguar Health Déclarations Prospectives Actualités Financières Webinaire Pour Les Investisseurs Traitements Gastro-intestinaux
BRIEF

published on 04/10/2026 at 02:20, 2 months 15 days ago

Jaguar Health Schedules Investor Webcast on Q4 2025 Financials

Financial Updates Forward-looking Statements Investor Webcast Jaguar Health Gastrointestinal Treatments
PRESS RELEASE

published on 04/10/2026 at 02:15, 2 months 15 days ago

Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Jaguar Health, Inc. announces participation details for upcoming webcast on April 10, 2026. Learn about their novel prescription drugs derived from plants for GI diseases

Forward-looking Statements Webcast Jaguar Health GI Diseases Prescription Drugs
BRIEF

published on 04/08/2026 at 14:35, 2 months 17 days ago

Jaguar Health achève l'essai du Crofelemer pour le CID chez les chiens

Crofelemer Jaguar Health Approbation De La FDA Chimiothérapie Canine Traitement De La Diarrhée
BRIEF

published on 04/08/2026 at 14:35, 2 months 17 days ago

Jaguar Health Completes Crofelemer Trial for CID in Dogs

Crofelemer FDA Approval Jaguar Health Dog Chemotherapy Diarrhea Treatment
PRESS RELEASE

published on 04/08/2026 at 14:30, 2 months 17 days ago

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. completes study on crofelemer for cancer therapy-induced diarrhea in dogs. Results expected to complement positive outcomes. Company plans to file effectiveness study by Q2 2026

Crofelemer Jaguar Health Cancer Therapy Diarrhea Dogs

Published on 06/25/2026 at 22:30, 42 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 1 hour 40 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 7 hours 42 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 8 hours 12 minutes ago

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 8 hours 42 minutes ago

Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations

View all ACCESSWIRE

Published on 06/25/2026 at 22:40, 31 minutes ago

DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 4 hours 11 minutes ago

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 4 hours 12 minutes ago

OHB Digital Connect completes upgrade of military ground stations
Published on 06/25/2026 at 18:40, 4 hours 31 minutes ago

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
Published on 06/25/2026 at 18:30, 4 hours 41 minutes ago

Delisting of Northern Data AG Shares - Munich Stock Exchange Decides on the Timeline

View all EQS

Published on 06/25/2026 at 18:45, 4 hours 26 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 4 hours 42 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 5 hours 22 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 06/25/2026 at 17:50, 5 hours 22 minutes ago

DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 06/25/2026 at 15:58, 7 hours 13 minutes ago

260625 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE

News